IGG3 Reactive Rheumatoid Factor in Rheumatoid: Arthritis: Etiologic and Pathogenic: Considerations

References

• Carson D. A. Rheumatoid Factor. Textbook of Rheumatology3rd ed., W. N. Kelley, E. D. Harris, Jr., S. Ruddy, C. B. Sledge. W.B. Saunders, Philadelphia 1989
   Google Scholar
• Munthe E., Natvig J. B. Immunoglobulin classes, subclasses and complexes of IgG rheumatoid factor in rheumatoid plasma cells. Clin. Exp. Immunol 1972; 12: 55
   PubMed Web of Science ®Google Scholar
• Williams R. C., Jr. Rheumatoid arthritis as a systemic disease. Major Problems Int. Med 1974; 4: 1–268
   PubMedGoogle Scholar
• Vaughan J. H. Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum 1993; 36: 1–6
   PubMedGoogle Scholar
• Munthe E., Nativig J. B. Complement fixing intracellular complexes of IgG rheumatoid factor in rheumatoid plasma cells. Scan. J. Immunol 1972; 1: 217–229
   PubMedGoogle Scholar
• Natvig J. B., Munthe E. Self‐associating IgG rheumatoid factor represents a major response of plasma cells in rheumatoid inflammatory tissue. Ann. NY Acad. Sci 1975; 256: 88–95
   PubMed Web of Science ®Google Scholar
• Kunkel H. G., Muller‐Eberhard H. J., Fudenberg H. H., Tomasi T. B. Gamma‐globulin complexes in rheumatoid arthritis and certain other conditions. J. Clin. Invest 1961; 40: 117–129
   PubMed Web of Science ®Google Scholar
• Winchester R. J., Agnello V., Kunkel H. G. Gamma‐globulin complexes in synovial fluids of patients with rheumatoid arthritis. II. Partial characterization and relationship to lowered complement leveles. Clin. Exp. Immunol 1970; 6: 689–706
   PubMed Web of Science ®Google Scholar
• Vaughn J. H., Barnett E. V., Sobel M. V., Jacox R. F. Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases. Arthritis Rheum 1968; 11: 125–134
   PubMedGoogle Scholar
• Barrett A. J. The possible role of neutrophi! proteinases in damage to articular cartilage. Agents Actions 1978; 8: 11–18
   PubMedGoogle Scholar
• Mohr W., Wessinghage D. The relationship between polymorphonuclear granulocytes and cartilage destruction in rheumatoid arthritis. Rheumatol 1978; 37: 81–86
   Google Scholar
• Kitsis E., Weissmann G. The role of the neutrophil in rheumatoid arthritis. Clin. Ortho. Related Res 1991; 265: 63–72
   Google Scholar
• Zvaifler N. J. The immunopathology of joint inflammation in rheumatoid arthritis. Adv. Immunol 1973; 16: 265–336
   PubMedGoogle Scholar
• Hedberg H. Studies on the depressed hemolytic complement activity of synovial fluid in adult rheumatoid arthritis. Acta Rheumatol. Scand 1963; 9: 165–193
   PubMedGoogle Scholar
• Pekin T. J., Zvaifler N. J. Measurement of hemolytic complement in synovial fluid. Arthritis Rheum 1962; 5: 314
   Google Scholar
• Ruddy S., Austen K. F. Complement system in rheumatoid synovitis. Arthritis Rheum 1973; 13: 713–723
   Google Scholar
• Robbins D. L., Fiegal D. W., Jr., Leek J. C., Shaprio R., Wiesner K. Complement activation by 19S IgM rheumatoid factor: Relationship to disease activity in rheumatoid arthritis. J. Rheumatol 1986; 13: 33–38
   PubMedGoogle Scholar
• Carson D. A., Chen P. P., Kipps T. J. New roles for rheumatoid factor. J. Clin. Invest 1991; 87: 379–383
   PubMed Web of Science ®Google Scholar
• Robbins D. L., Wistar R., Jr. Comparative specificities of serum and synovial cell 19S IgM rheumatoid factors in rheumatoid arthritis. J. Rheumatol 1985; 12: 437–443
   PubMedGoogle Scholar
• Butler V. P., Jr., Vaughan J. H. The reaction of rheumatoid factor with animal gammaglobulins: quantitative considerations. Immunol 1965; 8: 144–147
   PubMedGoogle Scholar
• Normansell D. E., Young C. W., Jr. The IgG subclass specificity of anti‐IgG immunoglobulin rheumatoid factors. Immunochem 1975; 12: 187–188
   Google Scholar
• Sasso E. H., Barber C. V., Nardella F. A., Yount W. J., Mannik M. Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors: The Cγ2‐Cγ3 interface region contains the major determinants. J. Immunol 1988; 140: 3098–3107
   PubMed Web of Science ®Google Scholar
• Deisenhofer J. Crystallographic refinement and atomic model of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9 and 2.8‐A resolution. Biochem 1981; 20: 2361–2370
   PubMed Web of Science ®Google Scholar
• Robbins D. L., Benisek W. F., Benjamini E., Wistar R. Jr. Differential reactivity of rheumatoid synovial cells and serum rheumatoid factors to human immunoglobulin G subclasses 1 and 3 and their CH3 domains in rheumatoid arthritis. Arthritis Rheum 1987; 30: 489–497
   PubMedGoogle Scholar
• Robbins D. L., Skilling J., Benisek W. F., Wistar R. Jr. Estimation of the relative avidity of 19S IgM rheumatoid factor secreted by rheumatoid synovial cells for human IgG subclasses. Arthritis Rheum 1986; 29: 722–729
   PubMedGoogle Scholar
• Randen I., Thompson K. M., Natvig J. B., Forre O., Waalen K. Human monoclonal rheumatoid factors derived from the polyclonal repertoire of rheumatoid synovial tissue: Production and characterization. Clin. Exp. Immunol 1989; 78: 13–18
   PubMedGoogle Scholar
• Bonagura V. R., Artandi S. E., Agostino N., Tao M. ‐H., Morrison S. L. Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies. DNA Cell Bio 1992; 11: 245–252
   PubMedGoogle Scholar
• Newkirk M. M., Rauch J. Monospecific but not polyre‐active human hybridoma rheumatoid factors exhibit preferential binding specificities for IgG3 and IgG4. Rheumatol. Int 1994; 13: 203–209
   PubMedGoogle Scholar
• Newkirk M. M., Lemmo A., Rauch J. Importance of the IgG isotype, not the state of glycosylation, in determining human rheumatoid factor binding. Arthritis Rheum 1990; 33: 800–809
   PubMedGoogle Scholar
• Wong A., Kenny T., Ermel R., Robbins D. Human monoclonal rheumatoid factor derived from rheumatoid synovial cells monospecific for rabbit IgG. J. Rheumatol 1993; 20: 623–629
   PubMed Web of Science ®Google Scholar
• Bonagura V. R., Artandi S. E., Davidson A., Randen I., Agostino N., Thompson K., et al. Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis‐derived monoclonal rhematoid factors. J. Immunol 1993; 151: 3840–3852
   PubMed Web of Science ®Google Scholar
• Brown C. M.S., Plater‐Zyberk C., Mageed R. A., Jefferis R., Maini R. N. Analysis of immunogloublins secreted by hybridomas derived from rheumatoid synovia. Clin. Exp. Immunol 1990; 80: 366–372
   PubMedGoogle Scholar
• Ermel R. W., Kenny T. P., Chen P. P., Robbins D. L. Molecular analysis of rheumatoid factors derived from rheumatoid synovium suggests an antigen‐driven response in inflamed joints. Arthritis Rheum 1993; 36: 380–388
   PubMedGoogle Scholar
• Nardella F. A., Teller D. C., Barber C. V., Mannik M. IgG rheumatoid factors and staphylococcal protein A bind to a common molecular site on IgG. J. Exp. Med 1985; 162: 1811–1824
   PubMed Web of Science ®Google Scholar
• Newkirk M. M., Rauch J., Commerford K. Binding characteristics of human hybridoma IgG and IgM rheumatoid factors: Influence of IgG isotype and carbohydrate content. J. Rheumatol 1992; 19: 54–55
   Google Scholar
• Haber P. L., Kubagawa H., Koopman W. J. Immunoglobulin subclass distribution of synovial plasma cells in rheumatoid arthritis determined by use of monoclonal anti‐subclass antibodies. Clin. Immunol. Immunopath 1985; 35: 346–351
   PubMedGoogle Scholar
• Mellbye O. J., Vartdal F., Pahle J., Mollnes T. E. IgG and IgA subclass distribution of total immunoglobulin and rheumatoid factors in rheumatoid tissue plasma cells. Scan. J. Rheumatol 1990; 19: 333–340
   PubMed Web of Science ®Google Scholar
• Mayumi M., Kuritani T., Kubagawa H., Cooper M. D. IgG subclass expression by human β lymphocytes and plasma cells: B lymphocytes precommitted to IgG subclass can be preferentially induced by polyclonal mitogens with T cell help. J. Immunol 1983; 130: 671–677
   PubMed Web of Science ®Google Scholar
• Johnstone R., Griffiths I. D., Calvert J. E. Analysis of the IgG subclass production from rheumatoid arthritis. Autoimmunity 1991; 10: 35–39
   PubMed Web of Science ®Google Scholar
• Roitt I. M. Essential ImmunologySixth ed. Black‐well Scientific Publications, Oxford 1988
   Google Scholar
• Shakib F., Stanworth D. R. IgG subclass composition of rheumatoid sera and joint fluids. Ann. Rheum. Dis 1976; 35: 236–263
   Google Scholar
• Hoffman W. L., Goldberg M. S., Smiley J. D. Immunoglobulin G3 subclass production by rheumatoid synovial tissue cultures. J. Clin. Invest 1982; 69: 136–144
   PubMedGoogle Scholar
• Stuart J. M., Huffstutter E. H., Townes A. S., Kang A. H. Incidence and specificity of antibodies of types I., I.I., III, I.V., and V collagen in rheumatoid arthritis and other rheumatic diseases as measured by I25—radioimmunoassay. Arthritis Rheum 1983; 26: 832–840
   PubMed Web of Science ®Google Scholar
• Rowley M., Tail B., Mackay I. R., Cunningham T., Phillips B. Collagen antibodies in rheumatoid arthritis. Significance of antibodies to denatured collagen and their association with HLA‐DR4. Arthritis Rheum 1986; 29: 174–184
   PubMedGoogle Scholar
• Petty R. E., Hunt D. W., Rosenberg A. M. Antibodies to type IV collagen in rheumatic diseases. J. Rheumatol 1986; 13: 246–253
   PubMedGoogle Scholar
• Tarkowski A., Klareskog L., Carlsten H., Herberts P., Koopman W. J. Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum 1989; 32: 1087–1092
   PubMed Web of Science ®Google Scholar
• Collins I., Morgan K., Clague R. B., Brenchley P. E.C., Holt P. J.L. IgG subclass distribution of antinative type II collagen and antidenatured type II collagen antibodies in patients with rheumatoid arthritis. J. Rheumatol 1988; 15: 770–774
   PubMedGoogle Scholar
• Watson W. C., Cremer M. A., Wooley P. H., Townes A. S. Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis: evidence of restricted IgG3 subclass expression and activation of complement C5 to C5a. Arthritis Rheum 1986; 29: 1316–1321
   PubMedGoogle Scholar
• Fukasawa Y., Kano S. Anti‐type II collagen antibodies in collagen disease. Japanese J. Clin. Path 1993; 41: 876–881
   PubMedGoogle Scholar
• Pereira R. S., Black C. M., Duance V. C., Jones V. E., Jacoby R. K., Welsh K. I. Disappearing collagen antibodies in rheumatoid arthritis. Lancet 1985; 2: 501–502
   PubMedGoogle Scholar
• Sato Y., Sato R., Watanabe H., Kogure A., Watanabe K., Nishimaki T., et al. Complement activating properties of monoreactive and polyreactive IgM rheumatoid factors. Ann. Rheum. Dis 1993; 52: 795–800
   PubMedGoogle Scholar
• Tokano Y., Arai S., Hashimoto H., Hirose S., Yagita H., Nakauchi H., et al. The distinct subgroup of patients with rheumatoid arthritis shown by IgG3‐reactive rheumatoid factor. Autoimmunity 1989; 5: 107–114
   PubMed Web of Science ®Google Scholar
• Parekh R., Roitt I. M., Isenberg D. A., Dwek R., Rademacher T. Age‐related galactosylation of the N‐linked oligosaccharides of human serum IgG. J. Exp. Med 1988; 167: 1731–1736
   PubMed Web of Science ®Google Scholar
• Mullinax F., Mullinax G. L. Abnormality of IgG struture in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1975; 18: 417–418
   Google Scholar
• Parekh R. B., Dwek R. A., Sutton B. J., Fernandes D. L., Leung A., Stanworth D., et al. Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation patten of total serum IgG. Nature 1985; 316: 452–457
   PubMed Web of Science ®Google Scholar
• Parekh R. B., Roitt I. M., Isenberg D. A., Dwek R. A., Ansell B., Rademacher T. W. Galactosylation of IgG associated oligosacchardies: reduction in patients with adult and juvenile onset rheumatoid arthritis and relation to disease activity. Lancet 1988; 1: 966–969
   PubMed Web of Science ®Google Scholar
• Rademacher T. W., Parekh R. B., Dwek R. A., Isenberg D., Rook G., Axford J. S., et al. The role of IgG glycoforms in the pathogensis of rheumatoid arthritis. Springer Seminars Immunopath 1988; 10: 231–249
   PubMedGoogle Scholar
• Tomana M., Schrohenloher R. E., Koopman W. J., Alarcón G. S., Paul W. A. Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum 1988; 31: 333–338
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Endo T., Matsuta K., Yoshinoya S., Aikawa T., Kosuge E., et al. Effects of galactose depletion from oligosaccharide chains on immunological activities of human IgG. J. Rheumatol 1989; 16: 285–290
   PubMed Web of Science ®Google Scholar
• Parekh R. B., Isenberg D., Rook G., Roitt I., Dwek R., Rademacher T. A comparative analysis of disease‐associated changes in the galactosylation of serum IgG. J. Autoimmun 1989; 2: 101–114
   PubMed Web of Science ®Google Scholar
• Rook G. A.W., Steele J., Brealey R., Whyte A., Isenberg D., Sumar N., et al. Changes in IgG glycoform levels are associated with remission of arthritis during pregnancy. J. Autoimmun 1991; 4: 779–794
   PubMed Web of Science ®Google Scholar
• Sumar N., Colao C. B., Bodman K. B., Parekh R., Williams P., Dwek R., et al. Abnormalities in the glycosylation of IgG in spouses of patients with rheumatoid arthritis. A family study. J. Autoimmun 1991; 4: 907–914
   PubMedGoogle Scholar
• Roitt I. M., Hutchings P. R., Dawe K. I., Sumar N., Bodman K. B., Cooke A. The forces driving autoimmune disease. J. Autoimmun 1992; 5: 11–26
   PubMedGoogle Scholar
• Lydyard P. M., Rook G. A.W., Tsoulfa G., Sharif M., Smith M. Is there a role for mycobacteria in the etiopatho‐genesis of rheumatoid arthritis?. Immunol. Rev 1991; 121: 137–154
   PubMedGoogle Scholar
• Axford J. S., Mackenzie L., Lydyard P. M., Hay F. C., Isenberg D. A., Roitt I. M. Reduced B‐cell galatosyl‐transferase activity in rheumatoid arthritis. Lancet 1987; 2: 1486–1488
   PubMed Web of Science ®Google Scholar
• Lunec J., Blake D. R., McCleary S. J., Brailsford S., Bacon P. A. Self‐perpetuating mechanisms of immuno‐globulin G aggregation in rheumatoid inflammation. J. Clin. Invest 1985; 76: 2084–2090
   PubMed Web of Science ®Google Scholar
• Griffiths H. R., Lunec J. The effects of oxygen free radicals on the carbohydrate moiety of IgG. FEBS Letters 1989; 245: 95–99
   PubMedGoogle Scholar
• Artandi S. E., Canfield S. M., Tao M. ‐H., Calame K. L., Morrison S. L., Bonagura V. R. Molecular analysis of IgM rheumatid factor binding to chimeric IgG. J. Immunol 1991; 146: 603–610
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Endo T., Shiota M., Kochibe N., Ito K., Kobata A. Distribution of glycosylation abnormality among serum IgG subclasses from patients with rheumatoid arthritis. Clin. Immunol. Immunopath 1994; 70: 47–50
   PubMedGoogle Scholar
• Allen J. C., Kunkel H. G. Hidden rheumatoid factors with specificity for native γ globulins. Arthritis Rheum 1966; 9: 758–768
   PubMed Web of Science ®Google Scholar
• Recht B., Frangione B., Franklin E., van Loghem E. Structural studies of a human γ3 myeloma protein (Goe) that binds Staph protein A. J. Immunol 1981; 127: 917–923
   PubMedGoogle Scholar
• Jefferis R., Nik Jaafer M. I., Steinitz M. Immunogenic and antigenic epitopes of immunoglobulins. VIII. A human monoclonal rheumatoid factor having specificity for a discontinuous epitope determined by histidine/ arginine interchange at residue 435 of immunoglobulin G. Immunol. Letters 1984; 7: 191–194
   PubMed Web of Science ®Google Scholar
• Steward M. W., Turner M. W., Natvig J. B., Gaarder P. I. The binding affinities of rheumatoid factors interacting with the Cγ3 homology region of human IgG. Clin. Exp. Immunol 1973; 15: 145–152
   PubMedGoogle Scholar
• Puttick A. H., Williamson E. A., Merry A. H., Kumpel B. M., Thompson K. M., Jones V. E. Reaction of rheumatoid factors with IgG3 monoclonal anti‐Rh (D) antibodies: more frequent reactivity to a monoclonal antibody of the Gm allotype G3m(5) in rheumatoid patients negative for G3m(5). Ann. Rheum. Dis 1988; 47: 898–905
   PubMedGoogle Scholar
• Fudenberg H. H., Kunkel H. G. Specificity of the reaction between rheumatoid factors and gammaglobulin. J. Exp. Med 1961; 114: 257–278
   PubMedGoogle Scholar
• Grubb R., Matsumoto H., Sattar M. A. Incidence of anti‐human Ig with restricted specificity in Japanese, Kuwaiti, and Swedish patients with rheumatoid arthritis. Arthritis Rheum 1988; 31: 60–62
   PubMedGoogle Scholar
• Grubb R., Kjellen L. On the origin of antibodies to immunogloublin genetic markers in rheumatoid arthiritis. Exp. Clin. Immunogenet 1989; 6: 88–98
   PubMedGoogle Scholar
• Williams R. C., Jr., Malone C. C., Casali P. Heteroclitic polyclonal and monoclonal anti‐Gm(a) and anti‐Gm(g) human rheumatoid factors react with epitopes induced in Gm(a‐), Gm(g‐) IgG by interaction with antigen or by nonspecific aggregation: A possible mechanism for the in vivo generation of rheumatoid factors. J. Immunol 1992; 149: 1817–1824
   PubMedGoogle Scholar
• Morell A., Skvaril F., Steinberg A. G., van Loghem E., Terry W. D. Correlations between the concentrations of the four subclasses of IgG and Gm allotypes in normal human sera. J. Immunol 1972; 108: 195–206
   PubMed Web of Science ®Google Scholar
• Sarvas H., Rautonen N., Makela O. Allotype‐associated differences in concentrations of human IgG subclasses. J. Clin. Immunol 1991; 11: 39–45
   PubMed Web of Science ®Google Scholar
• Yount W. J., Kunkel H. G., Litwin S. D. Studies of the Vi (y‐2c) subgroup of γ‐globulin. A relationship between concentration and genetic type among normal individuals. J. Exp. Med 1967; 125: 177–190
   PubMedGoogle Scholar
• Grubb R., Hallberg T., Hammarstrom L., Oxelius V. A., Smith C. I.E., Soderstörm R., et al. Correlation between deficiency of immunoglobulin subclass G3 and Gm allotype. Acta Path Microbiol. Immunol. Scand 1986; 94: 187–191
   Google Scholar
• Rautonen N., Sarvas H., Julkunen I., Pyhala R., Makela O. Gm allotypes influence the production of IgG3 but the effect is age‐dependent. Human Immunol 1991; 32: 72–77
   PubMedGoogle Scholar
• Robbins D. L., Kenny T. P., Snyder L. L., Ermel R. W., Larrick J. W. Allotypic dependency of the specificity and avidity of human monoclonal IgM rheumatoid factors derived from rheumatoid synovial cells. Arthritis Rheum 1993; 36: 389–393
   PubMedGoogle Scholar
• Wilder R. L., Crofford L. J. Do infectious agents cause rheumatoid arthritis?. Clin. Ortho. Related Res 1991; 265: 36–41
   Google Scholar
• Moreland L. W., Koopman W. J. Infection as a cause of arthritis. Current Opinion Rheumatol 1991; 3: 639–649
   PubMedGoogle Scholar
• Krieg A. M., Steinberg A. D. Retroviruses and auto‐immunity. J. Autoimmunity 1990; 3: 137–166
   PubMed Web of Science ®Google Scholar
• Kalden J. R., Herrmann M. Autoimmune diseases in humans, e.g. autoimmune rheumatic diseases. Intervirology 1993; 35: 176–185
   PubMedGoogle Scholar
• Fox R. I., Lotz M., Rhodes G., Vaughan J. H. Epstein‐Barr virus in rheumatoid arthritis. Clin. Rheumatol. Dis 1985; 11: 665–688
   PubMedGoogle Scholar
• Tosato G., Blaese R. M. Epstein‐Barr virus infection and immunoregulation in man. Adv. Immunol 1985; 37: 99–149
   PubMed Web of Science ®Google Scholar
• Krane S. M., Simon L. S. Rheumatoid arthritis: clinical features and pathogenetic mechanisms. Med. Clin. N. Amer 1986; 70: 263–284
   PubMed Web of Science ®Google Scholar
• Fox R. I., Lotz M., Rhodes G., Vaughan J. H. Epstein‐Barr virus in rheumatoid arthritis. Clin. Rheumatol. Dis 1985; 11: 665–688
   PubMedGoogle Scholar
• Birkenfeld P., Haratz N., Klein G., Sulitzeanu D. Cross‐reactivity between the EBNA‐1 p107 peptide, collagen, and keratin: Implications for the pathogenesis of rheumatoid arthritis. Clin. Immunol. Immunopath 1990; 54: 14–25
   PubMedGoogle Scholar
• Hammerman D., Gresser I., Smith C. Isolation of cytomegalovirus from synovial cells of a patient with rheumatoid arthritis. J. Rheumatol 1982; 9: 658–664
   PubMedGoogle Scholar
• Newkirk M. M., Gram H., Heinrich G. F., Ostberg L., Capra J. D., Wasserman R. Complete protein sequences of the variable regions of the cloned heavy and light chains of a human anti‐cytomegalovirus antibody reveal a striking similarity to human monoclonal rheumatoid factors of the Wa idiotypic family. J. Clin. Invest 1988; 81: 1511–1518
   PubMed Web of Science ®Google Scholar
• Rioux J. D., Larose Y., Brodeur B., Radzioch D., Newkirk M. M. Characteristics of four hybridoma antibodies specific for the pp65 protein of the HCMV and their relationship to human rheumatoid factors. Molecular Immunol 1994; 31: 585–597
   PubMedGoogle Scholar
• Tsuchiya N., Murayama T., Yoshionoya S., Matsuta K., Shiota M., Furukawa T., et al. Antibodies to human cytomegalovirus 65‐kilodalton Fc binding protein in rheumatoid arthritis: idiotypic mimicry hypothesis of rheumatoid factor production. Autoimmun 1993; 15: 39–48
   PubMed Web of Science ®Google Scholar
• Ferraro A. S., Newkirk M. M. Correlative studies of rheumatoid factors and anti‐viral antibodies in patients with rheumatoid arthritis. Clin. Exp. Immunol 1993; 92: 425–431
   PubMedGoogle Scholar
• Para M. F., Baucke R. B., Spear P. G. Immunoglobulin G (Fc)‐binding receptors on virions of herpes simplex virus type 1 and transfer of these receptors to the cell surface by infection. J. Virol 1980; 34: 512–520
   PubMed Web of Science ®Google Scholar
• Tsuchiya N., Malone C., Hutt‐Fletcher L. M., Williams R. C. Jr. Rheumatoid factors react with Fab fragments of monoclonal antibodies to herpes simplex virus types 1 and 2 Fc γ‐binding proteins. Arthritis Rheum 1991; 34: 846–55
   PubMedGoogle Scholar
• Tsuchiya N., Williams R. C., Jr., Hutt‐Fletcher L. M. Rheumatoid factors may bear the internal image of the Fey‐binding protein of herpes simplex virus type 1. J. Immunol 1990; 144: 4742–4748
   PubMed Web of Science ®Google Scholar
• Mouritsen S. Rheumatoid factors are anti‐idiotypic antibodies against virus‐induced anti‐Fc receptor antibodies. A hypothesis for the induction of some rheumatoid factors. Scan. J. Immunol 1986; 24: 485–490
   PubMed Web of Science ®Google Scholar
• Wilder R. L., Lafyatis R., Yocum D. E., Case J. P., Kumkumian G. K., Remmers E. F. Mechanisms of bone and cartilage destruction in rheumatoid arthritis: lessons from the streptococcal cell wall arthritis model in LEW/N rats. Clin. Exp. Rheumatol 1989; 3: 123–127
   Google Scholar
• Severijnen A. J., van Kleef R., Hazenberg M. P., van de Merwe J. P. Cell wall fragments from major residents of the human intestinal flora induce chronic arthritis in rats. J. Rheumatol 1989; 16: 1061–1068
   PubMed Web of Science ®Google Scholar
• Rook G. A.W., Lydyard P., Stanford J. Mycobacteria and rheumatoid arthritis. Arthritis Rheum 1990; 33: 431–35
   PubMedGoogle Scholar
• Bahr G. M., Rook G. A.W., Al‐Saffar M., Van Embden J., Standard J. L., Behbahani K. Antibody levels to myco‐acteria in relation to HLA type: evidence for non‐HLA‐linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin. Exp. Immunol 1988; 74: 211–215
   PubMed Web of Science ®Google Scholar
• Tsoufla G., Rook G. A.W., Van‐Embden J. D.A., Young D. B., Mehlert A., Isenberg D. A., et al. Raised serum IgG and IgA antibodies to mycobacterial antigens in rheumatoid arthritis. Ann. Rheum. Dis 1989; 48: 118–123
   PubMedGoogle Scholar
• Tsoufla G., Rook G. A.W., Bahr G. M., Sattar M. A., Behbehani K., Young D. B., et al. Elevated IgG antibody levels to the mycobacterial 65‐kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scan. J. Immunol 1989; 30: 519–527
   PubMedGoogle Scholar
• Karlsson‐Parra A., Soderstrom K., Perm M., Ivanyi J., Kiessling R., Klareskog L. Presence of human 65 kD heat shcok protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scan. J. Immunol 1990; 31: 283–288
   PubMedGoogle Scholar
• De Graeff‐Meeder E. R., Voorhorst M., van Eden W., Schuurman H. J., Huber J., Barkley D., et al. Antibodies to the mycobacterial 65‐kd heat shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am. J. Pathol 1990; 137: 1013–1037
   PubMedGoogle Scholar
• Ermel R., Kenny T., Benisek W., Roberts M., Robbins D. Allotype‐dependent stimulation of peripheral blood and synovial lymphocytes by IgG3 in rheumatoid arthritis. Clin. Immunol. Immunopath 1992; 63: 259–266
   PubMedGoogle Scholar
• Kalsi J., Isenberg D. Rheumatoid factor: primary or secondary event in the pathogenesis of RA?. Int. Arch. Allergy Immunol 1993; 102: 209–215
   PubMedGoogle Scholar
• Paliard X., West S. G., Lafferty J. A., Clements J. R., Kappler J. W., Marrack P., et al. Evidence for the effects of a superantigen in rheumatoid arthritis. Science 1991; 253: 325–329
   PubMed Web of Science ®Google Scholar
• He X., Goronzy J., Weyand C. Selective induction of rheumatoid factors by superantigens and human helper T cells. J. Clin. Invest 1992; 89: 673–680
   PubMed Web of Science ®Google Scholar
• Pascual V., Capra J. D. B‐cell superantigens?. Curr. Biol 1991; 1: 315–317
   PubMedGoogle Scholar
• Sasso E. H., Silverman G. J., Mannik M. Human IgM molecules that bind to staphylococcal protein A contain VH III heavy chains. J. Immunol 1989; 142: 2778–2783
   PubMed Web of Science ®Google Scholar
• Bahr G. M., Sattar M. A., Stanford J. L., Shaaban M. A., Al Shimali B., Siddiqui Z., et al. HLA‐DR and tuberculin tests in rheumatoid arthritis and tuberculosis. Ann. Rheum. Dis 1989; 48: 63–68
   PubMedGoogle Scholar
• Roudier J., Petersen J., Rhodes G. H., Luka J., Carson D. A. Susceptibility to rheumatoid arthritis maps to a T‐cell epitope shared by the HLA‐Dw4 DR b‐l chain and the Epstein‐Barr virus glycoprotein gp110. Proc. Natl Acad. Sci. USA 1989; 86: 5104–5108
   PubMed Web of Science ®Google Scholar
• Vaughan J. H., Kouri T., Petersen J., Roudier J., Rhodes G. H. On the etiology of rheumatoid arthritis. Scan. J. Rheum 1988; 74: 19–28
   Google Scholar
• Ebringer A., Khalafpour S., Wilson C. Rheumatoid arthritis and Proteus: a possible etiological association. Rheum. Int 1989; 9: 223–228
   PubMedGoogle Scholar
• Stenszky V., Kozma L., Szegedi G., Farid N. R. Interplay of immunoglobulin G heavy chain markers (Gm) and HLA in predisposing to systemic lupus nephritis. J. Immunogenetics 1986; 13: 11–17
   PubMedGoogle Scholar
• Wittingham S., Mathews J. D., Schanfield M. S., Tait B. D., Mackay I. R. HLA and Gm genes in systemic lupus erythematosus. Tissue and Antigens 1983; 21: 50–57
   PubMedGoogle Scholar
• Loftus M. G., Sanders P., De Lange G., Grennan D. M. Immunoglobulin heavy chain constant region variants in rheumatoid arthritis. Annals. Rheum. Diseases 1989; 48: 838–842
   PubMedGoogle Scholar
• Gregersen P. K., Silver J., Winchester R. J. The shared epitope hypothesis. Arthritis Rheum 1987; 30: 1205–213
   PubMed Web of Science ®Google Scholar
• Wallin J., Carlsson B., Strom H., Moller E. A DR4‐associated DR‐DQ haplotype is significantly associated with rheumatoid arthritis. Arthritis Rheum 1988; 31: 72–9
   PubMedGoogle Scholar